Financière de Tubize SA (EBR:TUB)

Market Cap	9.30B +51.4%
Revenue (ttm)	n/a
Net Income	93.23M +3.5%
EPS	2.09 +3.5%
Shares Out	44.51M
PE Ratio	99.79
Forward PE	n/a
Dividend	1.08 (0.52%)
Ex-Dividend Date	May 7, 2026

Volume	142
Open	209.00
Previous Close	209.00
Day's Range	208.40 - 210.00
52-Week Range	134.20 - 250.50
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 24, 2026

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1928
• Employees: 3
• Stock Exchange: Euronext Brussels
• Ticker Symbol: TUB

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 22, 2026

Data Sources Report a data error